In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, Ananda announces that the Company now has 441,097,220 ordinary shares of 0.2 p each in issue, each share carrying the right to one vote. This figure of 441,097,220 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which...
Ananda announces that 23,041,666 ordinary shares of 0.2 p each in the Company have been issued following the exercise of warrants at a price of 0.2 p per share. The warrants have been exercised by Melissa Sturgess, Chief Executive Officer of the Company. Sturgess is interested in 69,653,888 Ordinary Shares, representing 15.79 per cent of the Company’ s enlarged...
The Directors of Ananda are pleased to provide the following update to shareholders. In its negotiations with companies interested in acquiring the rights to the hapac ® technology, Liberty Herbal Technologies Limited became aware that its large capacity hapac ® sachet making machine, with an output of 4,000 sachets per hour at a capital cost of...
The Directors of Ananda are pleased to provide the following update to shareholders. In its negotiations with companies interested in acquiring the rights to the hapac ® technology, Liberty Herbal Technologies Limited became aware that its large capacity hapac ® sachet making machine, with an output of 4,000 sachets per hour at a capital cost of...
The Company is pleased to announce that iCAN has secured additional financing from Tress Capital Limited and Plaza Capital Limited through a convertible Loan note at a pre-money valuation for iCAN of USD20m. Ananda invested USD200, 000 in convertible loan notes issued by iCAN in August 2018. On 8 January 2020, USD100, 000 of Ananda’ s convertible loan notes were...
He received nine commendations and was also awarded a Winston Churchill Fellowship to examine ways to reduce drug related crime in the UK, with some of his proposals being implemented by the British Government. Peter has a Master’ s degree in Social Sciences from Exeter University. Peter has also served as a police adviser to a UK based Drug and Alcohol charity,...
In March 2019, iCAN raised a further CAD $4,000,000 from a group of Canadian investors via a loan note that is convertible into shares at a valuation of USD $20,000,000. Ananda holds USD $200,000 of loan notes convertible at a maximum valuation of USD $12,000,000. LHT launched hapac ® in Italy in late 2018.
CORPORATE UDPATE- CANNABIS CULTIVATION AND LICENCE APPLICATION. The directors of Ananda are pleased to provide the following update to shareholders. The submission contained all pertinent information regarding DJT Plants’ proposed growing operations in the UK.
CORPORATE UDPATE- CANNABIS CULTIVATION AND LICENCE APPLICATION. The directors of Ananda are pleased to provide the following update to shareholders. The submission contained all pertinent information regarding DJT Plants’ proposed growing operations in the UK.
The company was founded by Lorne Gertner, chairman and co-founder of the cannabis lifestyle brand Tokyo Smoke which was sold to Canopy Growth as part of a $250 m purchase of Haiku Brands in 2018.. MoCanna’ s first initiative is byMinistry, a cannabis centric lounge and cultural space to be opened in Toronto in late 2019. byMinistry’ s mission is to broaden and...
Andrew Hore @Hubinvest Quoted Micro 30 September 2019 #SHEP #BARK #KEP #BUD #NMRP #KDNC #PRIM #SMAP #LIFE #ANA #COIN #FSEN #PALM #NQMI #MMX #PTRO #MNO #ESC #EVE #SUS #MOSB #IDP #TXH #AIM #NEX #LSE #smallcaps #stockstowatch #StocksToTrade
CORPORATE UDPATE- CANNABIS CULTIVATION AND EXTRACTION. The directors of Ananda are pleased to provide the following update to shareholders. Application for Home Office licence to grow > 0.2% THC cannabis.
Andrew Hore Quoted #Micro 23 September 2019 #NYR #SHEP #DXSP #ANA #AFRI #KEP #AFHP #RUTH #SOG #FCRM #CLSU #AIQ #LWB #NWOR #CRL #ArBah #stockstowatch #stocksinnews #AIM #NEX #LSE
Hapac ® update and Grant of Options. The Directors of Ananda are pleased to provide shareholders with the following update on the Company’ s activities. Hapac ® is a dry herb medical cannabis inhalation system which was launched in various retail outlets in Italy in late 2018.
Ananda has received a TR-1, which is reproduced without amendment below. The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation No. 596/ 2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now...
Ananda Developments plc announces that at the annual general meeting held earlier today, all resolutions were duly passed. The directors of the Company accept responsibility for the contents of this announcement. The Directors believe that this market is growing due to an increasing number of states in the USA, as well as other countries around the world,...
The Company's updated Corporate Presentation is available on the Company’ s website at the Media tab or by emailing ir@ananadadevelopments.com. The directors of the Company accept responsibility for the contents of this announcement. Ananda Developments plc CEO Melissa Sturgess.
Ananda Developments plc announces that the Company has sent notice to shareholders convening the Company’ s annual general meeting, to be held at the offices of Shakespeare Martineau LLP, 6 th Floor, 60 Gracechurch Street, London EC3V 0 HR on 31 st July 2019 at 11.00 am. The directors of the Company accept responsibility for the contents of this announcement.
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company hereby announces that it has 418,055,554 ordinary shares of 0.2 p each in issue, each share carrying the right to one vote. This figure of 418,055,554 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which...
Initially, the Company’ s strategy was focused specifically on companies, projects or products in Israel, Canada and the Netherlands, although this strategy was broadened in September 2018 to permit investment in any jurisdiction which has well established laws in relation to medicinal cannabis. The regulatory framework surrounding medicinal cannabis...
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    329.17M

Featured Media

Company Profile

The Company has been established as a company to invest in the developing market for medicinal or therapeutic Cannabis derivatives, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain Cannabis or hemp derived cannabinoids. The Directors believe that this market is growing due to an increasing number of states in the USA, as well as other countries around the world, changing their laws to allow for products containing constituents of Medicinal Cannabis to be developed, approved and sold. Ananda’s investment strategy is to invest in companies, projects or products that are either progressing medicinal or therapeutic Cannabis research and development, or are developing or have already developed, products that contain Cannabis derived cannabinoids and require funding to progress work plans or commercialise products.

Classification

Market Indices-
Watchlist